User:TerriVandenDyssel/sandbox

Arianne Shadi Kourosh, MD, MPH
Arianne Shadi Kourosh, MD, MPH (born in Austin, TX) is a Massachusetts-based board-certified physician best known for her work in recognizing “zoom dysmorphic disorder”, a form of body dysmorphia that is caused by constant video meetings. (published : A Pandemic of Dysmorphia: “Zooming” into the Perception of Our Appearance)

EDUCATION

 * MPH: Harvard T.H. Chan School of Public Health (cannot find date) Master of Public Health
 * MD: University of Texas, Southwestern Medical School (June 24, 2009)
 * Dermatology Residency: the University of Texas Southwestern Medical Center (July 01, 2010 - June 30, 2012)
 * Internal Medicine Internship: Tulane Medical Center (June 22, 2009 - June 21, 2010)
 * BA: University of Virginia

HONORS & AWARDS

 * UT Southwestern Medical Center Department of Dermatology Award for Leadership
 * UT Southwestern Medical Center Department of Dermatology Award for Humanism and Professionalism
 * UT Southwestern Medical Center Department of Dermatology Award for Excellence in Dermatology
 * Texas Dermatological Society 1st Place for Oral Podium Competition
 * Partners in Excellence Award for outstanding contributions to the community
 * Ernesto Gonzalez Award for Outstanding Service to the Latino community
 * Harvard Medical School Dean's Community Service Award
 * 2020, Presidential Citation from American Academy of Dermatology for Outstanding Service in Covid19 Crisis
 * Massachusetts General Hospital's Clinician-Teacher Award
 * Boston's Top Doctors

In 2022, she AAD Presidential Citation for her leadership of a national task force to aid those affected human trafficking Named one of Medscape's 25 Rising Stars in Medicine.

ZOOM DYSMORPHIC DISORDER
"Throughout the pandemic, many of us have been spending hours a day on video calls, which can impact how we think about our appearance. We’re viewing ourselves much more frequently, for longer periods of time and from strange angles with technology, leading many to think negatively about their appearance, focus on perceived flaws, and seek cosmetic care. With the term Zoom dysmorphia, we hoped to spark a discourse in the medical community about a phenomenon that we were observing unique to the living conditions of the pandemic, which we were concerned may trigger or worsen body dysmorphic disorder (BDD) in our patients. However, it is important to make the distinction between a term like Zoom dysmorphia that is useful for education and awareness—from the actual medical term such as BDD, which has its own criteria for diagnosis for which we would refer to a mental health professional."

'A Pandemic of Dysmorphia: “Zooming” into the Perception of Our Appearance'Italic text Shauna M. Rice, Emmy Graber, and Arianne Shadi Kourosh

Published Online: 6 Nov 2020 https://doi.org/10.1089/fpsam.2020.0454

Learn how Zoom dysmorphia is impacting your patientsItalic text https://blog.massgeneralbrighamhealthplan.org/learn-how-zoom-dysmorphia-is-impacting-the-remote-workforce

PROFESSIONAL PUBLICATIONS

 * Improving Patient Advocacy Groups Through Smartphones: A Needs Assessment. Journal of the American Academy of Dermatology. Vol 69, Issue 3, p 493-494, September 2013.
 * Bridging Dermatologists with Patient Advocacy Groups Through Smartphones. JAMA Dermatology 2013.
 * Pathogenesis of Mucous Membrane Pemphigoid. Dermatol Clin. 2011 Jul; 29(3):479-84.
 * Therapeutic Approaches to Patients with Mucous Membrane Pemphigoid. Dermatol Clin. 2011 Oct;29(4):637-41.
 * Activation of the mesostriatal reward pathway with exposure to ultraviolet radiation (UVR) vs. sham UVR in frequent tanners. Addiction Biology 17: 68P686.
 * Tanning as a behavioral addiction. American Journal Drug Alcohol Abuse 36(5):284-90 (May 2010)
 * Hooked on Tanning: Why You Shouldn't Start. The Skin Cancer Foundation Journal. Vol 30. 2012.
 * Photosensitive Disorders in HIV. Cockerell and Calame: Cutaneous manifestations of HIV infection. Copyright 2010. Manson Publishing, 73 Corringham Road, London, NW11 7DL, UK.
 * Leprosy of Lucio and Latapí with extremity livedoid vascular changes. International Journal of Dermatology 2013;52(10):1245-7Psoriasis as the Marker of Underlying Systemic Disease. Skin Therapy Letter.  2008 Feb; 13(1):1-5.
 * Patient Advocacy in the Technological Age. Journal of the Dermatology Nurses Association. July/August 2013 - Volume 5 - Issue 4, pp: 187-237. Dermatologists and Social Media, Editorial & Commentary for June 2013 Dialogues in Dermatology.
 * A Girl With Cerebriform Palmar Plaques. Consultant For Pediatricians. 2013;12(7):317-318.

CURRENT POSITIONS

 * Massachusetts General Hospital Director of Dermatology, Community Health Program
 * Director of the Pigmentary Disorder and Multi-Ethnic Skin Clinic
 * MGH's Dermatology Department's Director of Community Health
 * Assistant Professor of Dermatology at Harvard Medical School
 * Faculty Advisor to the Harvard Literary Society
 * Member of Harvard Archery Club

RECENT POSITIONS

 * Editor-in-Chief of Dialogues in Dermatology, the American Academy of Dermatology's (AAD) official podcast and internationally subscribed educational program for physicians
 * Founding Director of MGH's Clinic for Pigmentary Disorders
 * Founder and Director of Project Phoenix, MGH's pro-bono tattoo removal program, assisting those escaping gangs and human trafficking to be safe and reintegrate into society
 * Has served to advocate for patients in the AAD's delegation to Congress to protect medical research and affordable care for patients with skin disease

ACCOMPLISHMENTS OF NOTE

 * Developed the Skin Advocate iPhone App a free application connecting patients with other patient advocacy organizations for their skin conditions
 * Committed to patient advocacy and solving public health problems for patients with skin disease